Krystal said it is on track to launch Vyjuvek in Germany in the middle of the year and in France later in 2025.

Krystal Biotech, Inc. (the "Company") (NASDAQ: KRYS), a commercial-stage biotechnology company, today welcomed the European Medicines Agency's (EMA's) announcement ...

The agreement with SNS follows similar arrangements made with reimbursement authorities in the United Kingdom (UK), Ireland, ...

When faced with chronic stress, why do some people develop anxiety and depressive symptoms while others show resilience?

A gene therapy to correct a mutation that causes maple syrup urine disease (MSUD) prevented newborn death, normalized growth, ...

And welcome to the Sarepta Therapeutics Fourth Quarter and Full Year 2024 Financial Results Conference Call. As a reminder, today’s program is being recorded. At this time, I’d like to turn the call ...

Alcohol addiction devastates millions of lives each year, tearing apart families and leaving lasting scars. Yet, amid the ...

By reanalyzing synthetic gene array datasets regarding single and double-knockout yeast mutants, and considering two theoretical models of cell growth, the authors reach the valuable conclusion that ...

Retinal gene therapy advancements may rewrite the book on treatments for age-related macular degeneration and diabetic eye diseases.

Researchers from the NIHR Moorfields Biomedical Research Centre and University College London have found that gene therapy improved visual acuity and preserved retinal structure in young children with ...

The funding will accelerate the development of Fuse's technology platform and pipeline of novel gene therapies. With its ...